There is currently limited understanding of sexually transmitted infection (STI) and sexual health among people who use illicit opioids (PWUIO), with the majority of research to date focused more narrowly on HIV and HCV among those who inject drugs. Also lacking is knowledge of whether medications to treat opioid use disorder (MOUD) and engagement in harm reduction such as opioid education and naloxone distribution may affect STI and sexual health among PWUIO through their impacts on substance use, sexual risk, and engagement in care, and if these effects differ among vulnerable subgroups. This proposed pilot research seeks to examine the effects of MOUD and harm reduction on STI and sexual health in a cohort study of PWUIO in New York City.
Influence of Substance Use Treatment and Harm Reduction Engagement on Sexual Health among People Who Use Illicit Opioids in New York City
Project dates: January 2021 - January 2022Principal Investigator: Scheidell, Joy